Dianthus Therapeutics (DNTH) Assets Average (2018 - 2025)
Historic Assets Average for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to $451.8 million.
- Dianthus Therapeutics' Assets Average rose 2493.26% to $451.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $451.8 million, marking a year-over-year increase of 2493.26%. This contributed to the annual value of $276.7 million for FY2024, which is 11081.2% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Assets Average stood at $451.8 million, which was up 2493.26% from $337.3 million recorded in Q2 2025.
- Dianthus Therapeutics' Assets Average's 5-year high stood at $451.8 million during Q3 2025, with a 5-year trough of $81.0 million in Q2 2023.
- Over the past 4 years, Dianthus Therapeutics' median Assets Average value was $185.9 million (recorded in 2023), while the average stood at $245.4 million.
- Per our database at Business Quant, Dianthus Therapeutics' Assets Average tumbled by 5613.63% in 2023 and then surged by 36361.4% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Assets Average (Quarter) stood at $123.6 million in 2022, then soared by 50.41% to $185.9 million in 2023, then soared by 95.84% to $364.1 million in 2024, then grew by 24.07% to $451.8 million in 2025.
- Its Assets Average stands at $451.8 million for Q3 2025, versus $337.3 million for Q2 2025 and $361.3 million for Q1 2025.